DWDavis C. Woodworth

Davis C. Woodworth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Davis C. Woodworth has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hippocampal asymmetry captures non–amyloid-related risk of memory decline and clinical progression

    by Elham Ghanbarian, Babak Khorsand, Lukai Zheng, Davis C. Woodworth, Crystal M. Glover, Maria M. Corrada, S. Ahmad Sajjadi, Joshua D. Grill, Ali Ezzati


  • Open Access

    Autoimmune antibodies and systemic inflammatory markers are prevalent and associated with cognition in individuals aged 90+

    by Ghasem Farahmand, Anne-Marie C Leiby, Jiaxin Yu, Aanan Ramanathan, Rojan Javaheri, Claudia H Kawas, Davis C Woodworth, Maria M Corrada, Tianchen Qian, S Ahmad Sajjadi

    Background: While recent studies have found associations between markers of autoimmunity/inflammation and cognitive performance in individuals aged 60–90, these findings remain unexplored in individuals aged 90 and above. Objective: To examine the prevalence of autoimmune antibodies and raised inflammatory markers and their associations with cognition in participants aged 90 + . Methods: We included participants with serological testing from The 90+ Study, a community-based longitudinal study in southern California. For measures of autoimmunity, we evaluated antinuclear, antineutrophil cytoplasmic (ANCA), rheumatoid factor, double stranded DNA, antithyroglobulin, and thyroid peroxidase antibodies. For inflammatory markers, we examined interleukin-6 (IL-6) and erythrocyte sedimentation rate (ESR). To examine the relationship between autoimmune antibodies and inflammatory markers with cognitive performance, we ran linear mixed effects models. Results: Among 201 participants (mean age 94.8 years, 56.7% female, 93.5% white, and 4.5% with rheumatologic illness), autoimmune antibodies were positive in 70.2%. Also, among 142 participants with test results, elevated inflammatory markers were detected in 76.8%. Linear mixed effects model analyses revealed an association between higher levels of ANCA ( p = 0.04), IL-6 ( p = 0.01), and ESR ( p = 0.01) and lower global cognitive scores. In a subset of participants with amyloid PET ( n = 173), results remained significant even after accounting for amyloid burden. Conclusions: Autoimmune antibodies and raised inflammatory markers were highly prevalent in a community cohort of individuals aged 90 + . Our results suggest that increased prevalence of autoimmunity and inflammation might be associated with worse cognitive performance in this age group, independent of amyloid.

  • Open Access

    Common neuropathologic change drivers of hippocampal sclerosis of ageing

    by Davis C Woodworth, Jerry J Lou, William H Yong, Elizabeth Head, María M Corrada, Peter T Nelson, S Ahmad Sajjadi

    Hippocampal sclerosis of ageing (HS-A)—severe cell loss and gliosis in the hippocampal formation—is a neuropathologic change (NC) that affects up to 20% of elderly persons with dementia. The aetiology of HS-A is heterogeneous, but HS-A is strongly associated with limbic-predominant age-related TDP-43 encephalopathy NC (LATE-NC). Other NCs have also been implicated in relation to HS-A, but these associations have been inconsistent across previous studies. Also, because LATE-NC and HS-A are so strongly associated, it is important to adjust for LATE-NC when examining associations between other NCs and HS-A. The goal of this study was to examine associations of other common NCs with HS-A, both before and after adjusting for LATE-NC. We analysed the National Alzheimer’s Coordinating Center (NACC) neuropathology dataset and examined associations of Alzheimer’s disease NC (ADNC), Lewy bodies (LB) and cerebrovascular NCs, with HS-A, adjusting for LATE-NC in multiple ways. We used Bayesian multilevel logistic regression models with monotonic modelling for ordinal predictors and report the odds ratios (OR) or average OR across levels (aOR), along with 95% credibility intervals (CI) as well as expected frequencies of HS-A for selected models and predictor levels. Of n = 1933 autopsy participants included (average age at death of 83 years, 51.3% women), HS-A was present in 278 (14.4%). LATE-NC was strongly associated with HS-A (aOR = 3.7, 95% CI = 2.8, 5.0). While ADNC showed a modest association with HS-A in models where LATE-NC was not included as a predictor (aOR = 1.4, CI = 1.1, 1.8), this association was reduced when adjusting for LATE-NC (aOR = 1.11, CI = 0.9, 1.5); results were similar for the ADNC-related A/B/C scores and limbic LBs. However, several cerebrovascular NCs were similarly associated with HS-A both without adjusting for LATE-NC [atherosclerosis aOR = 1.4, arteriolosclerosis aOR = 1.6, white matter rarefaction (WMR) aOR = 1.4] and with adjusting for LATE-NC (atherosclerosis aOR = 1.4, arteriolosclerosis aOR = 1.5, WMR aOR = 1.3). In a combined model, LATE-NC was strongly associated with HS-A, but global cerebrovascular NCs, as well as APOE-ε4 (increased odds) and education (decreased odds), were also associated with HS-A. Predicted HS-A frequency for predictor levels of no LATE-NC or global cerebrovascular NCs was 1.5% (CI = 0.6%, 3.1%), while it was 94.5% (CI = 84%, 99.5%) for LATE-NC stage 3 and severe global cerebrovascular NC levels. LATE-NC is likely the most important cause of HS-A. While ADNC seems to be associated with HS-A through its association with LATE-NC, the association of cerebrovascular NCs with HS-A independent of LATE-NC underlines the importance of vascular factors in the aetiology of HS-A.


  • Open Access

    Evaluating the updated LATE‐NC staging criteria using data from NACC

    by Davis C. Woodworth, Katelynn M. Nguyen, Lorena Sordo, Kiana A. Scambray, Elizabeth Head, Claudia H. Kawas, María M. Corrada, Peter T. Nelson, S. Ahmad Sajjadi

    INTRODUCTION: Limbic‐predominant age‐related TAR DNA‐binding protein of 43 kDa encephalopathy neuropathologic change (LATE‐NC) staging criteria were updated in 2023. We evaluated this updated staging using National Alzheimer's Coordinating Center data.METHODS: We examined associations of LATE‐NC stages with cognition and other neuropathologic changes (NCs), and with cognition while accounting for other NCs, using multilevel regression models.RESULTS: Of 1352 participants, 502 (37%) had LATE‐NC (23% stage 1a, 6% stage 1b, 58% stage 2, 13% stage 3). LATE‐NC stages were associated with cognition, hippocampal sclerosis of aging (HS‐A), Alzheimer's disease NC (ADNC), Lewy bodies (LBs), and hippocampal atrophy. While stage 1b was associated with cognition and HS‐A consistent with other stages, it was not associated with ADNC or LBs. All LATE‐NC stages remained significantly associated with worse cognition when accounting for other NCs.DISCUSSION: The updated LATE‐NC staging criteria capture variations in early TDP‐43 pathology spread which are consequential for cognition and associations with other NCs.Highlights: We applied the updated limbic‐predominant age‐related TAR DNA‐binding protein of 43 kDa encephalopathy neuropathologic change (LATE‐NC) staging criteria to data from the National Alzheimer's Coordinating Center. LATE‐NC stage 1b was identified in 22% of participants with stage 1. In contrast to other LATE‐NC stages, stage 1b was not associated with Alzheimer's disease neuropathologic change (ADNC) or Lewy bodies. Stages 1a and 1b were significantly associated with dementia and memory impairment. Stages 1b+ were more strongly tied to dementia than all other neuropathologic changes except high likelihood ADNC.


  • Open Access

    Novel quantitative method for characterization of hippocampal sclerosis and its association with other neuropathologies and cognitive deficits

    by Lorena Sordo, Tianchen Qian, Katelynn M. Nguyen, Syed A. Bukhari, Davis C. Woodworth, Thomas J. Montine, Elizabeth Head, María M. M. Corrada, Claudia H. Kawas, S. Ahmad Sajjadi

    Background: Hippocampal sclerosis of aging (HS) is characterized by neuronal loss and astrogliosis in subiculum and/or CA1 subfield of hippocampus. Using a novel quantitative approach, we studied the prevalence and localization of HS pathology in a well‐characterized oldest‐old cohort and examined its association with other neuropathologic changes and cognitive impairment.Methods: We studied 409 consecutive autopsied participants of The 90+ Study with longitudinal assessments. In those with HS by traditional method (presence/absence), we used digitized hematoxylin and eosin and luxol fast blue hippocampal slides for further quantitative analysis. Using QuPath, we measured the length of each hippocampal subfield partitioned into three subregions (Figure1). We then calculated the proportion affected by HS for each subregion. Both traditional (presence/absence) and quantitative (subfield‐specific proportions) measures were used to study the relationship between HS and other neuropathologic changes and cognitive outcomes using regression models adjusted for sex, age at death, and education with all neuropathologic changes as covariates.Results: HS was present in 11% of participants and was always focal, mostly affecting CA1 (89%), followed by subiculum (27%). Overlapping CA1/subiculum pathology was seen in 16% (Figure2). Left‐sided HS was more frequent (75%) than right‐sided (18%). Bilateral cases were the least frequent (7%). HS presence (traditional measure) was only associated with Limbic‐predominant age‐related TDP‐43 encephalopathy (LATE) (OR = 3.45, p36 = 4.11, p = 0.001) and LATE (t35 = 2.98, p = 0.005). HS proportion in subiculum alone was inversely associated with microvascular lesions (t41 = ‐3.16, p = 0.003) (Table1). HS proportion in subiculum and CA1 was associated with dementia at death and impairment of memory, language, calculation, and orientation. HS proportion in subiculum was additionally associated with impaired executive function. HS traditional measure was only associated with impaired orientation (Table1).Conclusion: Based on our novel quantitative analysis, HS pathology was always focal, mostly unilateral, and associated with dementia and impairment in major cognitive domains. We found associations between HS and vascular pathologies that were not detected using traditional measure. The associations of HS with dementia and impaired memory, language, and calculation, identified with our quantitative method, were not detected using traditional measure.

  • Open Access

    Association of LATE‐NC with other neuropathologies and cognition in the oldest‐old: Evidence from The 90+ Study and NACC

    by Davis C. Woodworth, Katelynn M. Nguyen, Syed A. Bukhari, Thomas J. Montine, Claudia H. Kawas, María M. M. Corrada, S. Ahmad Sajjadi

    Background: Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change (LATE‐NC) is a prevalent and important contributor to dementia. A previous study suggested that associations between LATE‐NC and other neuropathologies, namely Alzheimer’s disease neuropathologic change (ADNC) and Lewy bodies (LB), were attenuated in oldest‐old (≥90 years at death) compared to younger‐old individuals. However, this remains an open question. Our objectives were: Objective‐1) Examine the association of LATE‐NC with other neuropathologies and cognition in oldest‐old participants from The 90+ Study and National Alzheimer’s Coordinating Center (NACC). Objective‐2) Compare the associations of LATE‐NC with other pathologies and cognition in oldest‐old vs younger‐old NACC participants.Method: We included participants from both The 90+ Study and NACC, excluding those with frontotemporal lobar degeneration and rare pathologies. LATE‐NC was defined as presence of TDP‐43 in amygdala, hippocampus, or neocortex. Neuropathologies of interest were dichotomized as follows: ADNC: intermediate/high; LB: limbic/neocortical; hippocampal sclerosis (HS): presence; arteriolosclerosis, atherosclerosis, and cerebral amyloid angiopathy (CAA): moderate/severe. We used diagnoses of dementia and clinical AD as measures of cognitive function. For Objective‐1 we performed logistic regressions of LATE‐NC with neuropathologies and cognitive measures in oldest‐old participants from The 90+ Study and NACC. For Objective‐2 we tested the interaction between LATE‐NC and age‐group (≥90 vs 65‐90) for associations with neuropathologies and cognitive measures in NACC. Regressions were adjusted for sex and education.Result: Objective‐1): Both cohorts had similar prevalence of LATE‐NC in the oldest‐old (NACC, N = 393, 44% with LATE‐NC; 90+Study, N = 394, 37% with LATE‐NC, Table‐1). LATE‐NC was consistently associated with HS (PFigure‐1).Objective‐2): NACC participant characteristics are shown in Table‐1. We found trends for the interaction between LATE‐NC and age‐group for ADNC (P = 0.055, stronger in younger‐old) and arteriolosclerosis (P = 0.051, stronger in oldest‐old, Figure‐2).Conclusion: In the oldest‐old, associations of LATE‐NC with other neuropathologies and cognitive measures were consistent across two independent cohorts. The association of LATE‐NC with ADNC and arteriolosclerosis might be age dependent although further studies are needed.

  • Open Access

    Cerebral perfusion and amyloidosis in the oldest‐old

    by Shubir Dutt, Davis C. Woodworth, S. Ahmad Sajjadi, Claudia H. Kawas, María M. M. Corrada, Daniel A. Nation

    Background: Cerebrovascular contributions to cognitive aging and Alzheimer’s disease (AD) risk represent a growing field in aging research. Studies in the young‐old have demonstrated the critical role of vascular dysregulation (i.e., altered cerebral blood flow) in relation to cognitive decline prior to the appearance of amyloid/tau biomarkers. However, cerebral perfusion has not been well‐studied in the oldest‐old (ages 90 and over), a rapidly growing population that may provide unique insight into resilience and protective factors against dementia in later life. We characterized amyloid and cerebral perfusion profiles of cognitively normal (CN) and cognitively impaired without dementia (CIND) oldest‐old individuals.Method: Participants were 97 dementia‐free older adults (70 CN and 27 CIND) from the 90+ Study who had available neuroimaging (T1‐MRI, ASL‐MRI, Florbetapir‐PET), demographic, and clinical data. We examined differences between CN and CIND in regional perfusion in areas associated with AD risk (medial temporal lobe, posterior cingulate, precuneus, frontal cortex, inferior parietal lobe) and in amyloid burden using linear regression models controlling for age, sex, education, APOE4 status, and vascular risk factors.Result: CN and CIND groups did not differ in the characteristics compared (Table 1). CIND participants had lower CBF in the posterior cingulate/precuneus than the CN group, but groups did not differ in posterior cingulate/precuneus amyloid SUVR (Figure 1). Additionally, CIND had lower CBF than CN in the inferior parietal lobe but higher CBF in the medial temporal lobe and orbitofrontal cortex (Figure 2).Conclusion: CIND individuals had lower regional perfusion in the posterior cingulate/precuneus, but groups did not differ in amyloidosis, highlighting the relationship between cerebrovascular function and cognitive status in the oldest‐old independent of amyloidosis. Our findings complement previously reported posterior cingulate/precuneus hypoperfusion in younger‐old individuals with cognitive impairment and AD. Interestingly, we observed greater medial temporal/frontal perfusion in CIND than CN, similar to previous studies demonstrating initial hyperperfusion preceding hypoperfusion across the CN‐CIND‐Dementia spectrum. This may represent a compensatory vascular mechanism supporting cognition in individuals at greater risk of developing dementia. Future studies will further characterize this cohort with longitudinal perfusion analyses, neuropsychological correlates, and relationships between perfusion and other indices of cerebrovascular dysfunction.


  • Open Access

    Antemortem MRI detects atrophy related to hippocampal sclerosis pathology in the oldest‐old but side matters: The 90+ Study

    by Davis C. Woodworth, Janice X. Li, Sina Faramarzi, Dana E. Greenia, Syed A. Bukhari, Thomas J. Montine, Claudia H. Kawas, María M. M. Corrada, S. Ahmad Sajjadi

    Background: Hippocampal sclerosis of aging (HS) is the neuropathological finding of neuronal death and gliosis in the hippocampus. HS is more prevalent, and associated with dementia, in the oldest‐old (those ≥90 years), but cannot be diagnosed during life. HS is often unilateral and can be missed if only one brain hemisphere is assessed, which is standard neuropathological practice but may hamper the development of biomarkers for HS. Here we examined hippocampal volumes from antemortem MRI in relation to bilaterally‐assessed HS at autopsy, accounting for side, in oldest‐old participants from The 90+ Study.Method: We included participants with both autopsy and antemortem MRI data. All participants had neuropathological assessment of HS for both hemispheres. We performed hippocampal segmentation of antemortem 3D‐T1w MRIs using FreeSurfer, adjusting by intracranial volume. We compared total average (average of left and right), left, and right, hippocampal volumes between those with and those without HS. For HS participants we combined the hippocampal volumes from each hemisphere with HS into a single group and from each hemisphere without HS into a separate group, and compared these to the average hippocampal volumes from those without HS. We used Welch’s T‐tests for comparisons and report Cohen’s d effect sizes.Result: Participant characteristics (N = 89) are shown in Table‐1. All HS was unilateral (Right = 6, Left = 4). Average total hippocampal volume was not significantly different between those with and those without HS (d = 0.51, P = 0.11, Figure‐1a). However, right hippocampal volumes were significantly related to right‐sided HS with a large effect size (P = 0.002, d = 1.02) and left hippocampal volumes had a large effect size for left‐sided HS (P = 0.17, d = 0.90, Figure‐1c), whereas this was not the case when HS was on the opposite side (P>0.3, dFigure‐1b,c). Combined HS participant hippocampal volumes for the side with HS (d = 0.98, P = 0.003), but not the side without HS (d = ‐0.14, P = 0.7), were different from volumes in participants without HS (Figure‐1d).Conclusion: Our results suggest HS is detectable by atrophy on antemortem MRI, but most strongly when using hippocampal volumes from the same side as HS. Researchers should consider assessing and documenting the presence of HS in both hemispheres to accelerate development of neuroimaging biomarkers for HS.

  • Open Access

    Antemortem MRI detects atrophy related to hippocampal sclerosis pathology in the oldest‐old but side matters: The 90+ Study

    by Davis C. Woodworth, Janice X. Li, Sina Faramarzi, Dana E. Greenia, Syed A. Bukhari, Thomas J. Montine, Claudia H. Kawas, María M. M. Corrada, S. Ahmad Sajjadi

    Background: Hippocampal sclerosis of aging (HS) is the neuropathological finding of neuronal death and gliosis in the hippocampus. HS is more prevalent, and associated with dementia, in the oldest‐old (those = 90 years), but cannot be diagnosed during life. HS is often unilateral and can be missed if only one brain hemisphere is assessed, which is standard neuropathological practice but may hamper the development of biomarkers for HS. Here we examined hippocampal volumes from antemortem MRI in relation to bilaterally‐assessed HS at autopsy, accounting for side, in oldest‐old participants from The 90+ Study.Method: We included participants with both autopsy and antemortem MRI data. All participants had neuropathological assessment of HS for both hemispheres. We performed hippocampal segmentation of antemortem 3D‐T1w MRIs using FreeSurfer, adjusting by intracranial volume. We compared total average (average of left and right), left, and right, hippocampal volumes between those with and those without HS. For HS participants we combined the hippocampal volumes from each hemisphere with HS into a single group and from each hemisphere without HS into a separate group, and compared these to the average hippocampal volumes from those without HS. We used Welch’s T‐tests for comparisons and report Cohen’s d effect sizes.Result: Participant characteristics (N = 89) are shown in Table‐1. All HS was unilateral (Right = 6, Left = 4). Average total hippocampal volume was not significantly different between those with and those without HS (d = 0.51, P = 0.11, Figure‐1a). However, right hippocampal volumes were significantly related to right‐sided HS with a large effect size (P = 0.002, d = 1.02) and left hippocampal volumes had a large effect size for left‐sided HS (P = 0.17, d = 0.90, Figure‐1c), whereas this was not the case when HS was on the opposite side (P>0.3, d<0.4, Figure‐1b,c). Combined HS participant hippocampal volumes for the side with HS (d = 0.98, P = 0.003), but not the side without HS (d = ‐0.14, P = 0.7), were different from volumes in participants without HS (Figure‐1d).Conclusion: Our results suggest HS is detectable by atrophy on antemortem MRI, but most strongly when using hippocampal volumes from the same side as HS. Researchers should consider assessing and documenting the presence of HS in both hemispheres to accelerate development of neuroimaging biomarkers for HS.

  • Open Access

    Dementia is associated with medial temporal atrophy even after accounting for neuropathologies

    by Davis C. Woodworth, Nasim Sheikh-Bahaei, Kiana A. Scambray, Michael J. Phelan, Mari Perez-Rosendahl, María M. Corrada, Claudia H. Kawas, Seyed Ahmad Sajjadi, For The Alzheimer'S Disease Neuroimaging Initiative

    Brain atrophy is associated with degenerative neuropathologies and the clinical status of dementia. Whether dementia is associated with atrophy independent of neuropathologies is not known. In this study, we examined the pattern of atrophy associated with dementia while accounting for the most common dementia-related neuropathologies. We used data from National Alzheimer’s Coordinating Center (n = 129) and Alzheimer’s Disease Neuroimaging Initiative (n = 47) participants with suitable in vivo 3D-T1w MRI and autopsy data. We determined dementia status at the visit closest to MRI. We examined the following dichotomized neuropathological variables: Alzheimer’s disease neuropathology, hippocampal sclerosis, Lewy bodies, cerebral amyloid angiopathy and atherosclerosis. Voxel-based morphometry identified areas associated with dementia after accounting for neuropathologies. Identified regions of interest were further analysed. We used multiple linear regression models adjusted for neuropathologies and demographic variables. We also examined models with dementia and Clinical Dementia Rating sum of the boxes as the outcome and explored the potential mediating effect of medial temporal lobe structure volumes on the relationship between pathology and cognition. We found strong associations for dementia with volumes of the hippocampus, amygdala and parahippocampus (semi-partial correlations ≥ 0.28, P < 0.0001 for all regions in National Alzheimer’s Coordinating Center; semi-partial correlations ≥ 0.35, P ≤ 0.01 for hippocampus and parahippocampus in Alzheimer’s Disease Neuroimaging Initiative). Dementia status accounted for more unique variance in atrophy in these structures (∼8%) compared with neuropathological variables; the only exception was hippocampal sclerosis which accounted for more variance in hippocampal atrophy (10%). We also found that the volumes of the medial temporal lobe structures contributed towards explaining the variance in Clinical Dementia Rating sum of the boxes (ranging from 5% to 9%) independent of neuropathologies and partially mediated the association between Alzheimer’s disease neuropathology and cognition. Even after accounting for the most common neuropathologies, dementia still had among the strongest associations with atrophy of medial temporal lobe structures. This suggests that atrophy of the medial temporal lobe is most related to the clinical status of dementia rather than Alzheimer's disease or other neuropathologies, with the potential exception of hippocampal sclerosis.